12:15 PM EST - Bausch Health Companies Inc. : And its gastroenterology business, Salix Pharmaceuticals,, one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases, today announced the presentation of two scientific posters featuring rifaximin data at the American Association for the Study of Liver Diseases (AASLD) annual meeting, The Liver Meeting Digital Experience, which will take place Nov. 13-16. Bausch Health Companies Inc.
shares T.BHC are trading down $0.16 at $25.24.
